A. B. GÜZEL Et Al. , "Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.23, no.5, pp.603-608, 2008
GÜZEL, A. B. Et Al. 2008. Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.23, no.5 , 603-608.
GÜZEL, A. B., KASAP, H., Tuncer, I., Ozgunen, K., SERTDEMİR, Y., KASAP, M., ... ÖZCAN, N.(2008). Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.23, no.5, 603-608.
GÜZEL, AHMET Et Al. "Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.23, no.5, 603-608, 2008
GÜZEL, AHMET B. Et Al. "Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.23, no.5, pp.603-608, 2008
GÜZEL, A. B. Et Al. (2008) . "Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.23, no.5, pp.603-608.
@article{article, author={AHMET BARIŞ GÜZEL Et Al. }, title={Suppression of the Tumorigenicity of B-16V Melanoma Cells via Lysozyme Gene}, journal={CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS}, year=2008, pages={603-608} }